MAPK1 and acute lymphoblastic leukemia: Zhao et al. reported that HOXA-AS2 regulated the HOXA3/EGFR/Ras/Raf/MAPK kinase/ERK pathway to reduce the sensitivity of glucocorticoids in acute lymphoblastic leukemia 54.